SFV HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Earnings and revenue for health care facility landlord LTC Properties Inc. exceeded Wall Street expectations for the fourth quarter and the full year.
MannKind Corp. on Tuesday announced it has received the remaining $16.7 million after closing the sale of some of its former real estate at 28901-28903 N. Avenue Paine in Valencia.
Moving clinics off hospital campuses into non-medical locations that are also prominent and convenient is a new strategy for many major health systems.
The stock of Amgen Inc. rose more than 2 percent Wednesday following an announcement that the Thousand Oaks biotechnology firm has applied for the Food and Drug Administration’s approval to broaden the range of disease conditions that can be treated with its leukemia drug Blincyto.
Health insurer Cigna Corp. on Tuesday announced it had terminated its merger agreement with Anthem Inc. and had filed a lawsuit seeking more than $13 billion in damages from the company.
A federal judge ruled in favor of the Justice Department in a civil antitrust lawsuit to block health insurer Anthem, Inc.’s acquisition of Cigna Corp.
Amgen Inc.’s cholesterol drug Repatha will continue to have competition for the time being.
Glendale health management company Apollo Medical Holdings Inc. on Thursday announced the launch of its interactive platform Apollo Care Connect 4.0.
Atara Biotherapeutics Inc., a clinical-stage biopharmaceutical company headquartered in South San Francisco, will move its research and development division to Thousand Oaks by the end of the year, according to the Conejo Valley city.
Amgen Inc. on Tuesday announced that the U.S. Food and Drug Administration has approved its drug Parsabiv for the treatment of secondary hyperparathyroidism in adult patients with chronic kidney disease on hemodialysis.
Knoxville-based TeamHealth Holdings has agreed to pay $60 million plus interest to settle a case brought against its subsidiary IPC Healthcare Inc., according to the Department of Justice.
Amgen Inc. on Friday announced it has appointed Charles Holley, the former chief financial officer of Wal-Mart Stores Inc., to its board of directors.
Second Sight Medical Products Inc. announced that the German health care system has approved reimbursement coverage for the Argus II Retinal Prosthesis system in certain hospitals throughout the country.
Amgen Inc. reported financial results that beat analyst expectations for the fourth quarter.
MannKind Corp. plans a reverse stock split to remain listed on the Nasdaq Stock Market, pending shareholder approval.